Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
By E. Amir, Bostjan Seruga, S. Niraula, Lindsay Carlsson, A. Ocaña. Journal of the National Cancer Institute, 2011
598 citations recorded by the source corpus.
Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Genetics
View Paper: https://www.semanticscholar.org/paper/09f09130dbfa16259acecdc2d3b611757d718e51
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
Citations in the corpus
- Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. (2013, background): “Well-known adverse effects include hot flashes, thrombotic events, and a small risk of endometrial cancer.(22) However, despite the possibility that all patients were not able to complete the prescribed course of treatment, local control, distant disease-free survival, and cancer-specific survival r”
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (2013, background): “for those with pre-existing ischaemic cardiovascular disease [87, 88].”